Innoviva
INVA
#5190
Rank
โ‚น136.79 B
Marketcap
โ‚น1,830
Share price
-2.38%
Change (1 day)
17.12%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): โ‚น13.73 Billion

According to Innoviva's latest financial reports the company's current earnings are โ‚น0.38 Billion. In 2024 the company made an earning of โ‚น3.39 Billion a decrease over its 2023 earnings that were of โ‚น17.63 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น13.73 B304.35%
2024 โ‚น3.39 B-80.74%
2023 โ‚น17.63 B-32.36%
2022 โ‚น26.06 B-35.56%
2021 โ‚น40.44 B25.7%
2020 โ‚น32.17 B52.11%
2019 โ‚น21.15 B10.77%
2018 โ‚น19.09 B56.59%
2017 โ‚น12.19 B125.53%
2016 โ‚น5.40 B-417.36%
2015 -โ‚น1.71 Billion-74.49%
2014 -โ‚น6.68 Billion-25.19%
2013 -โ‚น8.93 Billion430.06%
2012 -โ‚น1.69 Billion-83.92%
2011 -โ‚น10.48 Billion39.82%
2010 -โ‚น7.5 Billion2.84%
2009 -โ‚น7.29 Billion-8.62%
2008 -โ‚น7.98 Billion-47.92%
2007 -โ‚น15.32 Billion-5.92%
2006 -โ‚น16.28 Billion19.8%
2005 -โ‚น13.59 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-โ‚น1.65 Billion-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-โ‚น14.49 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA